Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1573-904X
    Keywords: glioma ; sustained release ; microsphere ; carboplatin ; BCNU
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract Purpose. Delivery of chemotherapeutics using implantable,biodegradable polymers provides a potentially powerful method of treating braintumors. The present studies examined the ability of injectablemicrospheres, formulated to release carboplatin or BCNU for 2–3 weeks,to enhance survival in a rodent model of deep, inoperable glioma. Methods. Rat glioma (RG2) cells were implanted into the striatum ofrats. In a first experiment, the tumors were allowed to grow for 3 days,followed by either no treatment, bolus chemotherapy (100 μg), orimplantation of microspheres containing 10, 50, or 100 μg ofcarboplatin. The microspheres were implanted, via hypodermic injection,directly into the center of the small, 3-day-old tumors. In a secondexperiment, tumors grew for 8 days prior to treatment with eithercarboplatin- or BCNU-loaded microspheres. The microspheres werethen injected either directly into the center of these larger tumors orinto three sites along the perimeter of the tumor. Separate sets ofanimals received bolus chemotherapy (100 μg) into either the tumorcenter or around the tumor perimeter. Results. Injection of carboplatin-loaded microspheres into the centerof the small 3 day old, tumors produced dose-related increases insurvival. When injections of carboplatin- or BCNU-loadedmicrospheres were made into the center of the larger, 8-day-old tumors,survival was not enhanced. However, when the microspheres wereinjected along the perimeter of the larger tumors, sustained-releasechemotherapy did significantly prolong survival. Bolus chemotherapywas less effective than sustained release chemotherapy. Conclusions. Together, these data: (1) demonstrate that sustaineddelivery of chemotherapy in or near the tumor site is superior toequipotent bolus doses in inoperable tumors, (2) demonstrate thatinjection of sustained release microspheres into the tissue surroundinga growing tumor may provide superior effects over injections directlyinto the tumor mass, and (3) suggest that this approach may providea useful means of selectively delivering chemotherapeutics to tumorsor portions of tumors that cannot otherwise be treated with conventionalsurgical approaches.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1573-904X
    Keywords: glioma ; sustained release ; microsphere ; carboplatin ; BCNU
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract Purpose. Implantation of biodegradable polymers provides a powerfulmethod to deliver high, sustained concentrations of chemotherapeuticsto brain tumors. The present studies examined the ability of injectablepolymeric microspheres, formulated to release carboplatin or BCNUfor 2–3 weeks, to enhance survival in a rodent model ofsurgically-resected glioma. Methods. Rat glioma (RG2) cells were implanted into the cortex ofrats and allowed to grow for 10 days prior to surgical resection. Ratswere given either surgical resection only, bolus injection (100 μg) ormicrospheres containing 10, 50, or 100 μg of carboplatin or BCNU.The microspheres were implanted, via hypodermic injection, eitherdirectly into the surgical cavity or into the tissue along the perimeterof the cavity. Results. The order of survival among treatment groups was: noresection 〈 resection only 〈 bolus chemotherapy 〈 sustained releasechemotherapy. Carboplatin and BCNU did not differ in this respectand in each case, the enhanced survival achieved with sustained releasewas dose-related. However, the enhanced survival achieved withcarboplatin was substantially greater when the microspheres wereimplanted into the perimeter wall of the resection cavity, compared toimplantation into the cavity itself. The enhanced survival produced bycarboplatin implants along the resection perimeter was associated witha significant attenuation of regrowth of the tumor. Finally, in a separatestudy in non-tumor brain, atomic absorption spectrophotometryrevealed that while the microspheres produced significantly prolongedtissue levels of carboplatin relative to a bolus injection, carboplatindiffusion was limited to brain tissue extending primarily 0.5 mm fromthe injection site. Conclusions. These data demonstrate: (1) that sustained delivery ofchemotherapy is superior to equipotent bolus doses following tumorresection, and (2) that direct injection of sustained release microspheresinto the tissue surrounding a growing tumor mass may provide superioreffects over injections into the surgical cavity. They also suggest thatsuccessful implementation of this approach in humans may requiremeasures or circumstances that improve upon the limited spatial drugdiffusion from the implantation site.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1573-904X
    Keywords: blood-brain tumor barrier ; bradykinin ; brain metastases ; carboplatin ; carmustine ; paclitaxel ; vinorelbine ; gemcitabine
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract Purpose. The following experiments determined whether intravenous infusions of Cereport enhance delivery of chemotherapeutics and prolong survival in rats with metastatic tumors in the brain. Methods. Autoradiography and scintillation were used to examine uptake of the lipophilic (paclitaxel and carmustine) and the hydrophilic (carboplatin) chemotherapeutic agents, as well as the large hydrophilic marker, 70 kDa dextran. Cereport was also tested in combination with the chemotherapeutic drugs carboplatin, vinorelbine, gemcitabine and carmustine to determine if Cereport could enhance the survival benefit beyond that provided by chemotherapy alone. Results. Cereport enhanced the uptake of carboplatin and dextran, but not paclitaxel or carmustine. The pattern of Cereport's uptake effect with carboplatin revealed that Cereport selectively increased the proportion of highly permeable regions. Survival was significantly enhanced when Cereport was combined with either carboplatin, vinorelbine, or gemcitabine, but not carmustine, compared to each chemotherapeutic agent alone. Conclusions. These data provide the first evidence that Cereport, or any receptor-mediated approach intended to enhance the permeability of the blood-brain tumor barrier, can increase the delivery hydrophilic drugs to metastatic tumors in the brain, increasing survival in tumor-bearing rats.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...